This
study aimed to confirm the effects of Tibet kefir milk (TKM)
on gut microbiota and metabolism. An obesity model was established
by feeding a high-fat diet (HFD) to human-microbiota-associated rats.
Next-generation sequencing and ultrahigh-performance liquid chromatography-quadrupole
time-of-flight mass spectrometry were applied for gut microbiota and
untargeted metabolomics, respectively. After 8 weeks of feeding, the
enterotype in the HFD group was switched from ET1 (Prevotella/Akkermansia-dominant) to ET2 (Bacteroides/Akkermansia-dominant). Branched-chain amino-acids-
and aromatic amino-acids-metabolism increased, and taurine-conjugated
bile acids decreased in the HFD group. Compared with the HFD group,
taurocholic acid increased in the TKM1 group, while l-threonine
decreased, and equol, taurochenodeoxycholate, and taurodeoxycholic
acid increased in the TKM2 group. The metabolite alteration suggested
restorative bile acid metabolism, modified metabolic pattern of amino
acids, and elevation of anti-obesity factors in the TKM-intervened
animals. It can be deduced that changes by TKM intervention in the
host gut metabolites are the major contributors to reducing fat deposition.